Trial Profile

A phase 1 open‐label, single‐center, 2‐period, fixed‐sequence study of atogepant on the pharmacokinetics (PK) of oral contraceptive components ethinyl estradiol (EE) and levonorgestrel (LNG) in healthy postmenopausal or oophorectomized adult females

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

16 Apr 2020 Results assessing Atogepant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants, published in the Journal of Clinical Pharmacology
15 Nov 2019 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com